Insider · CIK 0001332456

Labinger Barry

Reports to the SEC for 4 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001332456

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-08-04	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+86K sh	—	—	85,950
2020-08-06	Checkmate Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+446K sh	—	—	445,819
2015-11-13	EBSEmergent BioSolutions Inc.S Sale	EVP, Biosciences Div.	SSale	−3,376 sh	$36.50	−$123K	25,182
2015-11-12	EBSEmergent BioSolutions Inc.M Exercise/Conversion	EVP, Biosciences Div.	MExercise/Conversion	+10.1K sh	$20.94	+$211K	40,323
2015-11-12	EBSEmergent BioSolutions Inc.S Sale	EVP, Biosciences Div.	SSale	−10.1K sh	$36.00	−$363K	30,229
2015-11-12	EBSEmergent BioSolutions Inc. · Stock OptionM Exercise/Conversion	EVP, Biosciences Div.	MExercise/Conversion	−10.1K sh	—	—	0
2015-11-11	EBSEmergent BioSolutions Inc.S Sale	EVP, Biosciences Div.	SSale	−6,564 sh	$35.51	−$233K	30,229
2015-11-11	EBSEmergent BioSolutions Inc.M Exercise/Conversion	EVP, Biosciences Div.	MExercise/Conversion	+9,373 sh	$28.09	+$263K	39,602
2015-11-11	EBSEmergent BioSolutions Inc.S Sale	EVP, Biosciences Div.	SSale	−9,373 sh	$35.50	−$333K	30,229
2015-11-11	EBSEmergent BioSolutions Inc.M Exercise/Conversion	EVP, Biosciences Div.	MExercise/Conversion	+10.1K sh	$20.94	+$211K	40,324
2015-11-11	EBSEmergent BioSolutions Inc.S Sale	EVP, Biosciences Div.	SSale	−10.1K sh	$35.50	−$358K	30,229
2015-11-11	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Biosciences Div.	FTax Payment	−1,671 sh	$35.88	−$60K	28,558
2015-11-11	EBSEmergent BioSolutions Inc. · Stock OptionM Exercise/Conversion	EVP, Biosciences Div.	MExercise/Conversion	−9,373 sh	—	—	0
2015-11-11	EBSEmergent BioSolutions Inc. · Stock OptionM Exercise/Conversion	EVP, Biosciences Div.	MExercise/Conversion	−10.1K sh	—	—	0
2015-03-10	EBSEmergent BioSolutions Inc.A Award	EVP, Biosciences Div.	AAward	+10.8K sh	—	—	38,387
2015-03-10	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Biosciences Div.	FTax Payment	−1,594 sh	$29.00	−$46.2K	36,793
2015-03-10	EBSEmergent BioSolutions Inc. · Employee Stock Option (right to buy)A Award	EVP, Biosciences Div.	AAward	+21.5K sh	—	—	21,517
2014-11-12	EBSEmergent BioSolutions Inc.F Tax Payment	EVP, Biosciences Div.	FTax Payment	−1,577 sh	$24.41	−$38.5K	27,625
2014-03-11	EBSEmergent BioSolutions Inc.A Award	EVP, Biosciences Div.	AAward	+14.1K sh	$28.09	+$395K	29,202
2014-03-11	EBSEmergent BioSolutions Inc. · Employee Stock Option (right to buy)A Award	EVP, Biosciences Div.	AAward	+28.1K sh	—	—	28,119
2013-11-12	EBSEmergent BioSolutions Inc.A Award	EVP, Biosciences Div.	AAward	+15.1K sh	—	—	15,412
2013-11-12	EBSEmergent BioSolutions Inc. · Employee Stock Option (right to buy)A Award	EVP, Biosciences Div.	AAward	+30.3K sh	—	—	30,284
2012-07-30	HUMAN GENOME SCIENCES INCU Disposition from Tender	Exec VP & CCO	UDisposition from Tender	−49.8K sh	$14.25	−$710K	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−117K sh	$14.25	−$1.67M	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−39K sh	$14.25	−$556K	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−53.1K sh	$14.25	−$757K	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−108K sh	$14.25	−$1.54M	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−37.5K sh	$14.25	−$534K	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−55.2K sh	$14.25	−$787K	0
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Exec VP & CCO	DDisposition to Issuer	−300K sh	$14.25	−$4.28M	0
2012-07-25	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+21.9K sh	$0.52	+$11.4K	40,242
2012-07-25	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+9,600 sh	$4.92	+$47.2K	49,842
2012-07-25	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−9,600 sh	—	—	39,015
2012-07-25	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−21.9K sh	—	—	53,140
2012-03-10	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyA Award	Exec VP & CCO	AAward	+108K sh	—	—	108,000
2011-07-26	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+8,000 sh	$10.62	+$85K	8,000
2011-07-26	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+7,306 sh	$10.11	+$73.9K	15,306
2011-07-26	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+3,056 sh	$4.92	+$15K	18,362
2011-07-26	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−8,000 sh	—	—	117,000
2011-07-26	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−3,056 sh	—	—	48,615
2011-07-26	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−7,306 sh	—	—	55,194
2011-05-27	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+3,205 sh	—	—	3,205
2011-05-02	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+7,347 sh	$4.92	+$36.1K	7,347
2011-05-02	HUMAN GENOME SCIENCES INCS Sale	Exec VP & CCO	SSale	−7,347 sh	$30.00	−$220K	0
2011-05-02	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−7,347 sh	—	—	51,671
2011-04-28	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+28.1K sh	$0.52	+$14.6K	28,113
2011-04-28	HUMAN GENOME SCIENCES INCM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	+11.9K sh	$4.92	+$58.3K	39,966
2011-04-28	HUMAN GENOME SCIENCES INCS Sale	Exec VP & CCO	SSale	−11.9K sh	$30.00	−$356K	28,113
2011-04-28	HUMAN GENOME SCIENCES INCS Sale	Exec VP & CCO	SSale	−28.1K sh	$30.00	−$843K	0
2011-04-28	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyM Exercise/Conversion	Exec VP & CCO	MExercise/Conversion	−11.9K sh	—	—	59,018

Recent filings

Accepted (ET)
Aug 64
Labinger Barry0000899243-21-031908
SEC(opens sec.gov)
Aug 104
Labinger Barry0000899243-20-021901
SEC(opens sec.gov)
Nov 174
Emergent BioSolutions Inc.0001140361-15-042070
SEC(opens sec.gov)
Nov 134
Emergent BioSolutions Inc.0001140361-15-041198
SEC(opens sec.gov)
Mar 124
Emergent BioSolutions Inc.0001140361-15-011531
SEC(opens sec.gov)
Dec 294
Emergent BioSolutions Inc.0001140361-14-046543
SEC(opens sec.gov)
Mar 124
Emergent BioSolutions Inc.0001140361-14-012349
SEC(opens sec.gov)

Companies

Address

14200 SHADY GROVE ROAD

ROCKVILLE, MD, 20850